Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons

Vaccine

Volumn 17, Issue 17, 1999, Pages 2166-2175

  Vinner, Lasse ^a   Nielsen, Henrik V ^a   Bryder, Karin ^a   Corbet, Sylvie ^a   Claus Nielsen, ^a   Fomsgaard, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Codon usage; DNA vaccination; HIV 1

Indexed keywords

DNA VACCINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; PLASMID DNA; SYNTHETIC DNA;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CODON USAGE; ENVELOPE GENE; FEMALE; GENE GUN; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS ENVELOPE;

AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; BIOLISTICS; CODON; CYTOKINES; FEMALE; GENES, ENV; GENES, REV; GENES, SYNTHETIC; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 0033597120     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00474-5     Document Type: Article

References (32)

1. Webster R.G., Robinson H.L. DNA vaccines: a review of developments. Biopharmaceuticals. 4:1997;273-292.
2. Steimer K.S., Scandella C.J., Skiles P.V., Haigwood N.L. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to gp120. Science. 254:1991;105-108.
3. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:1993;6642-6647.
4. Broder C.C., Earl P.L., Long D., Abedon S.T., Moss B., Doms R.W. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 91:1994;11699-11703.
5. Moore J.P. HIV vaccines: back to primary school. Nature. 376:1995;115.
6. Chou K.C., Zhang C.T. Diagrammatization of codon usage in 339 human immunodeficiency virus proteins and its biological implication. AIDS Res. Hum. Retroviruses. 8:1992;1967-1976.
7. Haas J., Park E.C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:1996;315-324.
8. Schwartz S., Felber B.K., Pavlakis G.N. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:1992;150-159.
9. André S., Seed B., Eberle J., Schraut W., Bültmann A., Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1998;1497-1503.
10. Fuller D., Haynes J.R. A qualitative progression in HIV type glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein120 vaccine. AIDS Res. Hum. Retrovir. 10:1994;1433-1441.
11. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:1993;4156-4160.
12. Lasky L.A., Groopman J.E., Fennie C.W., Benz P.M., Capon D.J., Dowbenko D.J., Nakamura G.R., Nunes W.M., Renz M.E., Berman P.W. Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science. 233:1986;209-212.
13. Fomsgaard A., Nielsen H.V., Nielsen C., Johansson K., Machuca R., Bruun L., Hansen J., Buus S. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus. APMIS. 106:1998;535-546.
14. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature. 329:1987;840-842.
15. Nielsen C.M., Bygbjerg I.C., Vestergaard B.F. Detection of HIV antigens in eluates from whole blood collected on filterpaper. Lancet. 1:1987;566-567.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
17. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin C subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
18. Gurgo C., Guo H.-G., Franchini G., Aldovini A., Collalti E., Farrell K., Wong-Staal F., Gallo R.C., Reitz M.S. Jr. Envelope sequence of two new United States HIV-1 isolates. Virology. 164:1988;531-536.
19. Harada S., Koyanagi Y., Yamamoto N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 229:1985;563-566.
20. Takahashi H., Merli S., Putney S.D., Houghten R., Moss B., Germain R.N., Berzofsky J.A. A single amino acid interchange yields reciprocal CTL specificity for HIV-1 gp160. Science. 246:1989;118-121.
21. Marker O., Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1973;1511-1525.
22. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T-helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
23. Johnson P.R., Fomsgaard A., Allan J., Gravell M., London W.T., Olmsted R.A., Hirsch V.M. Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J. Virol. 64:1990;1086-1092.
24. Fomsgaard A., Hirsch V.M., Allan J.S., Johnson P.R. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology. 182:1991;397-402.
25. Berman P.W., Matthews T.J., Riddle L., Champe M., Hobbs M.R., Nakamura G.R., Mercer J., Eastman D.J., Lucas C., Langlois A.J., Wurm F.M., Gregory T.J. Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. J. Virol. 66:1992;4464-4469.
26. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
27. Sonehara K., Saito H., Kuramoto E., Yamamoto S., Yamamoto T., Tokunaga T. Hexamer palindromic oligonucleotides with 5′-CG-3′ motif(s) induce production of interferon. J. Interferon. Cytokine. Res. 16:1996;799-803.
28. Pisetsky D.S. Immunostimulatory DNA: a clear and present danger? Nat. Med. 3:1997;829-831.
29. Roman M., Orozco E.M., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Korbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T-helper-1-promoting adjuvants. Nat. Med. 3:1997;849-854.
30. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
31. Muraille E., Leo O. Revisiting the Th1/Th2 paradigm. Scand. J. Immunol. 47:1998;1-9.
32. Inchauspe G., Vitvitski L., Major M.E., Jung G., Spengler U., Maisonnas M., Trepo C. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16:1997;185-195.